Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Lanx gets DeMane: Former Medtronic Chief Operating Officer Michael DeMane is now the chairman and CEO of spine device firm Lanx, the privately held company announced June 7. DeMane moves from his post at venture capital firm Thomas, McNerney and Partners, which he joined last year following his departure from Medtronic in 2008, when the firm eliminated its COO post (1"The Gray Sheet" May 5, 2008). He was an executive at Smith & Nephew and then spine firm Sofamor Danek Group until Medtronic acquired Sofamor in 1999. DeMane subsequently ran Medtronic's spinal systems business. In 2005, he took the helm of Medtronic's Europe, Canada, Latin America and Emerging Markets division, prior to becoming COO in 2007. Lanx markets 10 spinal fusion product lines, including the Telluride minimally invasive system and the BioLanx biologics line
Advertisement

Related Content

People In Brief
People In Brief
Medtronic CEO Tinkers With Organization To Begin New Fiscal Year
Medtronic CEO Tinkers With Organization To Begin New Fiscal Year

Topics

Advertisement
UsernamePublicRestriction

Register

MT029009

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel